pharmaceutical investing AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma
pharmaceutical investing AbbVie to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
pharmaceutical investing Allergan Aesthetics Unveils the Layered Beauty Report, Advancing the Global Conversation Around Aesthetic Care
pharmaceutical investing SkinMedica® Adds Barrier Calming Cream to its Collection of Regenerative Skincare Offerings
pharmaceutical investing AbbVie Submits Regulatory Application to EMA for SKYRIZI® Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease
pharmaceutical investing AbbVie to Present New Data at WCLC 2026 Showcasing Innovation Across Lung Cancer Pipeline
pharmaceutical investing AbbVie Announces 2026 AbbVie Immunology Scholarship Recipients, Celebrating 10 Years of Support
pharmaceutical investing Allergan Aesthetics Refreshes Allergan Partner Privileges® to Better Support Today's Modern Aesthetics Practices
pharmaceutical investing Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One
pharmaceutical investing Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence
pharmaceutical investing UBRELVY® Recommended for Reimbursement by Canada's Drug Agency for Acute Migraine Treatment
